Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
128,616,529
-
Shares change
-
+5,965,108
-
Total reported value, excl. options
-
$1,591,015,441
-
Value change
-
+$86,595,360
-
Put/Call ratio
-
77%
-
Number of buys
-
113
-
Number of sells
-
-62
-
Price
-
$12.37
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2024
216 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q4 2024.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 128,616,529 shares
of 189,947,836 outstanding shares and own 68% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (18,202,009 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (9,622,104 shares), BlackRock, Inc. (9,360,163 shares), MAVERICK CAPITAL LTD (8,261,242 shares), Driehaus Capital Management LLC (6,712,449 shares), M28 Capital Management LP (5,664,548 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,098,866 shares), Kynam Capital Management, LP (4,899,497 shares), Bellevue Group AG (4,094,458 shares), and 683 Capital Management, LLC (3,785,000 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.